Astrazeneca PLC ORD SHS $0.25
Astrazeneca PLC ORD SHS $0.25/ GB0009895292 /
AZN
|
9/11/2024 2:45:16 PM
|
Chg.
-106.4320
|
Volume |
Bid2:45:31 PM |
Ask2:45:31 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
12,299.5680GBX
|
-0.86%
|
57,499
Turnover(GBP): 7.03 mill. |
12,302.0000Bid Size: 203 |
12,306.0000Ask Size: 268 |
190.17 bill.GBP |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
3.84 USD |
81.13% |
| EPS Diluted: |
- USD |
80.57% |
| Revenues per Share: |
29.55 USD |
3.28% |
| Book Value per Share: |
25.25 USD |
5.68% |
| Cash Flow per Share: |
6.67 USD |
5.46% |
| Dividend per Share: |
2.90 USD |
0.00% |
| Total |
in mill. |
|
| Revenues: |
45,811.00 USD |
3.29% |
| Net Income: |
5,955.00 USD |
84.48% |
| Operating Cash Flow: |
10,345.00 USD |
- |
| Cash and Cash Equivalents: |
5,840.00 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
41.79 |
35.16 |
| P/S Ratio: |
5.43 |
4.57 |
| P/BV ratio: |
6.35 |
5.35 |
| P/CF Ratio: |
24.04 |
20.23 |
| PEG: |
0.52 |
0.43 |
| Earnings Yield: |
2.39% |
2.84% |
| Dividend Yield: |
1.81% |
2.15% |
| Market Capitalization |
|
| Market Capitalization: |
190.17 bill. GBP |
164.16 bill. GBP |
| Free Float Market Cap.: |
- GBP |
- GBP |
| Market Cap. / Employee: |
2.12 mill. GBP |
1.83 mill. GBP |
| Shares Outstanding: |
1.55 bill. |
|
Profitability
| Gross Profit Margin: |
81.95% |
| EBIT Margin: |
17.88% |
| Net Profit Margin: |
13.00% |
| Return on Equity: |
15.21% |
| Return on Assets: |
5.89% |
Financial Strength
| Liquidity I / Cash Ratio: |
19.12% |
| Liquidity II / Quick Ratio: |
58.82% |
| Liquidity III / Current Ratio: |
82.03% |
| Debt / Equity Ratio: |
158.33% |
| Dynam. Debt / Equity Ratio: |
599.09% |
Efficiency
| Employees: |
89,900 |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
509,577.31 USD |
| Net Income / Employee: |
66,240.27 USD |
| Total Assets / Employee: |
1,124,794.22 USD |
| * Fiscal Year End: |
12/31/2023 |
| Accounting Standard: |
IFRS |
